Skip to main content
Inside Cooper
  • CooperHealth.org
  • Request an Appointment
  • Cooper Blogs
Inside Cooper

Inside Cooper

Menu
  • Newsmakers
  • Press Releases
  • Announcements
  • Events
  • About This Blog
    • Participation Guidelines
    • Comment Policy

Vascular and Endovascular Surgery

Cooper Surgeon Performs NJ’s First FDA-Approved Drug-Coated Balloon Procedure for PAD

October 16, 2014 Leave a Comment
On October 15, 2014, Joseph V. Lombardi, MD, FACS, Head of the Division of Vascular and Endovascular Surgery and Director of the Cooper Aortic Center at Cooper University Health Care, was the first surgeon in New Jersey to treat advanced peripheral arterial disease (PAD) in a patient using the innovative Lutonix® 035 Drug-Coated Balloon (DCB) percutaneous transluminal angioplasty (PTA) Catheter
Posted in: Announcements, Newsmakers, Press Releases Tagged: Joseph V. Lombardi, MD, Vascular and Endovascular Surgery

Search

Recent Posts

  • Cooper University Health Care Among First in U.S. to Use Next-Generation SEISMIQ™ Intravascular Lithotripsy System
  • MD Anderson at Cooper Earns FACT Accreditation—Offering South Jersey’s Only Stem Cell Transplant Program
  • Cooper University Health Care Announces Major New $300 Million Gloucester Township Campus
  • Cooper University Hospital Earns National Accreditation for Comprehensive Bariatric Surgery Program Including Adolescent Care
  • Cooper Physician and Army Reserve Colonel Reaffirms Commitment to Service During Regional Readiness Exercise

Categories

  • Announcements
  • Careers
  • Events
  • Health Information
  • Newsmakers
  • Press Releases
  • Research

Copyright © 2026 Inside Cooper.

Magazine WordPress Theme by themehall.com

Accessibility by WAH